Lilly, IU Expanding Clinical Trial Access, Latest Treatments For Hoosiers
A new agreement under which Eli Lilly and Company will provide up to $40 million to Indiana University aims to expand access to clinical trials in Indiana, giving patients a pathway to Lilly’s latest investigational and innovative medicines while surrounding them with exceptional care.
Read More












